Can Prostate Cancer Be Cured? A 2026 Guide

For many men with prostate cancer, treatment aimed at cure is possible depending on the risk group—but the word "cure" cannot be applied the same way at every stage. Low-risk, intermediate-risk, and high-risk disease are treated with the goal of curative (radical) treatment, while metastatic disease that has spread to bone or elsewhere has a treatment goal of long-term control rather than cure.

Key Takeaways

• Korea's 5-year relative survival rate for prostate cancer is 96.9%, up 37.7 percentage points from patients diagnosed in 1993–1995 (National Cancer Registration Statistics 2019–2023, National Cancer Center Korea Central Cancer Registry).
• In the United States, the SEER 2016–2022 5-year relative survival rate is 98.2%. Both figures are nationwide statistics, not results from any single hospital.
• Low-risk prostate cancer is one of the rare cancers where active surveillance—monitoring at set intervals without treatment—is included as a standard option.
• Intermediate-risk, high-risk, and locally advanced stages can be treated with surgery or radiation therapy with the goal of cure.
• Metastatic disease can often be controlled for a long time with hormone therapy as the backbone of treatment, but it is not a stage where cure is the treatment goal.

Can Prostate Cancer Be Completely Cured?

• The answer depends on the risk group. Prostate cancer treatment is determined by combining PSA level, Gleason score (Grade Group 1 through 5), and stage into a risk group, along with the patient's age and any coexisting conditions.
• Low-risk cases (low PSA, lowest Grade Group, small tumor confined within the prostate) often progress slowly, which is why active surveillance—monitoring without treatment—is included as a standard option. If signs of progression appear, treatment begins at that point.
• For intermediate-risk disease, both radical prostatectomy and radiation therapy are standard treatments aimed at cure. For high-risk or locally advanced disease, surgery may be combined with lymph node dissection, or radiation may be combined with several years of hormone therapy, both aiming for cure.
• Metastatic disease (spread to bone or other organs) can often be controlled for a long time with hormone therapy as the backbone of treatment, but this is not a stage where cure is the treatment goal, and the duration of control varies by individual.

From Diagnosis to Treatment Plan: What Is the Sequence?

• Step 1: If PSA blood test levels are elevated or a digital rectal exam shows abnormalities, a prostate MRI is typically obtained first.
• Step 2: If the MRI shows a suspicious area, an MRI-fusion targeted biopsy of that site yields the Gleason score and Grade Group (1 through 5). A higher Grade Group indicates a more aggressive cancer.
• Step 3: MRI is used to check for invasion of the prostate capsule, and for higher-risk cases, a bone scan or PSMA PET is used to check for metastasis.
• Step 4: PSA, Grade Group, and stage are combined to determine the risk group, and factors such as age, life expectancy, and coexisting conditions are considered in choosing among active surveillance, surgery, radiation therapy, and hormone therapy.
• Step 5: After treatment, PSA is measured at set intervals to check for recurrence. For patients who had surgery, the goal is for PSA to drop to a nearly undetectable level; for patients who had radiation therapy, the goal is for PSA to gradually decline and stabilize at its lowest point (nadir).

Are Surgery and Radiation Therapy Equally Effective? What About Side Effects?

• In intermediate-risk disease, both radical prostatectomy and radiation therapy are standard treatments, and the choice is often based less on differences in outcomes than on differences in the nature of the side effects.
• Robotic radical prostatectomy is widely used for localized prostate cancer surgery and is known to be favorable for nerve preservation, typically requiring a hospital stay of 5 to 7 days. A urinary catheter is kept in place for some time after surgery, and urinary incontinence occurs in nearly all patients initially, generally improving over several months.
• With radiation therapy and particle therapy, urinary symptoms or changes in bowel habits are common during treatment and usually subside within a few weeks afterward, though late effects can rarely appear months to years later.
• Korea has extensive experience with robotic prostatectomy, and carbon-ion (heavy particle) therapy became available starting in 2023. For localized prostate cancer, carbon-ion therapy is typically completed in around 12 sessions, and eligibility depends on factors such as prior radiation history, presence of an artificial hip joint, and bowel/bladder condition.

FAQ — Can Prostate Cancer That Has Spread to Bone Still Be Treated?

Metastatic prostate cancer can often be controlled for a long time with hormone therapy as the backbone of treatment. Using anti-androgen agents or chemotherapy together from the start has become standard, combined with bone-protecting medications and radiation therapy to relieve pain. However, this is not a stage where cure is the treatment goal, and the duration of control varies by individual.

FAQ — Which Hospital Do These Survival Rates Come From?

These are not results from any single hospital but nationwide statistics for all of Korea (National Cancer Registration Statistics 2019–2023, National Cancer Center Korea Central Cancer Registry). Under Korean medical law, individual hospital outcome data is not used in advertising, and because outcomes vary significantly by risk group and stage, this single average figure cannot be used to predict any individual's course.

Sources and Notes

• This article was prepared based on National Cancer Registration Statistics 2019–2023 (National Cancer Center Korea Central Cancer Registry), U.S. SEER 2016–2022 data, the National Cancer Information Center, and NCCN patient guidelines.
• This content is provided for general medical information purposes only. Diagnosis, treatment methods, and outcomes may vary depending on individual circumstances. Please consult with your medical team to determine an accurate diagnosis and treatment plan.